NCT01705132 Urinary Biomarkers of the Progression of Alport Kidney Disease Status COMPLETED Phase N/A
NCT01703169 Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia Status COMPLETED Phase PHASE2
NCT01693003 Indacaterol Versus Tiotropium on Dynamic Hyperinflation in COPD Status COMPLETED Phase PHASE4
NCT01682213 Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation Status COMPLETED Phase PHASE2
NCT01680094 Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART Status COMPLETED Phase PHASE1/PHASE2
NCT01676714 Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01668173 HSP90 Inhibitor, AUY922, in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), and Refractory PV/ET Status TERMINATED Phase PHASE2
NCT01666236 Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy Status WITHDRAWN Phase PHASE4
NCT01666197 Efficacy and Safety of Diclofenac Potassium 25 mg Tablet Taken Three Times Daily in Subjects With Acute Joint Pain Status COMPLETED Phase PHASE4
NCT01663220 Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT01663207 Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes Status COMPLETED Phase N/A
NCT01656252 Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission Status TERMINATED Phase PHASE1/PHASE2
NCT01653847 Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens Status COMPLETED Phase NA
NCT01653041 Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors Status COMPLETED Phase PHASE4
NCT01648465 Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors Status TERMINATED Phase PHASE2
NCT01642017 Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria Status TERMINATED Phase PHASE1
NCT01630824 Development and Effects of a Structural Education Program in Adult Kidney Transplant Recipients Status UNKNOWN Phase NA